Sign Out
Clear to slightly opalescent, and colourless to pale brown solution.
Each vial contains 300 mg of ocrelizumab in 10 mL at a concentration of 30 mg/mL. The final drug concentration after dilution is approximately 1.2 mg/mL.
Ocrelizumab is a humanised monoclonal antibody produced in Chinese Hamster Ovary cells by recombinant DNA technology.
Excipients/Inactive Ingredients: Sodium acetate trihydrate, Glacial acetic acid, Trehalose dihydrate, Polysorbate 20, Water for injection.
